Skip to main content
Top
Published in: BMC Anesthesiology 1/2018

Open Access 01-12-2018 | Case report

Liver maximum capacity (LiMAx) test as a helpful prognostic tool in acute liver failure with sepsis: a case report

Authors: Matthias Buechter, Guido Gerken, Dieter P. Hoyer, Stefanie Bertram, Jens M. Theysohn, Viktoria Thodou, Alisan Kahraman

Published in: BMC Anesthesiology | Issue 1/2018

Login to get access

Abstract

Background

Acute liver failure (ALF) is a life-threatening entity particularly when infectious complications worsen the clinical course. Urgent liver transplantation (LT) is frequently the only curative treatment. However, in some cases, recovery is observed under conservative treatment. Therefore, prognostic tools for estimating course of the disease are of great clinical interest. Since laboratory parameters sometimes lack sensitivity and specificity, enzymatic liver function measured by liver maximum capacity (LiMAx) test may offer novel and valuable additional information in this setting.

Case presentation

We here report the case of a formerly healthy 20-year old male caucasian patient who was admitted to our clinic for ALF of unknown origin in December 2017. Laboratory parameters confirmed the diagnosis with an initial MELD score of 28 points. Likewise, enzymatic liver function was significantly impaired with a value of 147 [> 315] μg/h/kg. Clinical and biochemical analyses for viral-, autoimmune-, or drug-induced hepatitis were negative. Liver synthesis parameters further deteriorated reaching a MELD score of 40 points whilst clinical course was complicated by septic pneumonia leading to severe hepatic encephalopathy grade III-IV, finally resulting in mechanical ventilation of the patient. Interestingly, although clinical course and laboratory data suggested poor outcome, serial LiMAx test revealed improvement of the enzymatic liver function at this time point increasing to 169 μg/h/kg. Clinical condition and laboratory data slowly improved likewise, however with significant time delay of 11 days. Finally, the patient could be dismissed from our clinic after 37 days.

Conclusion

Estimating prognosis in patients with ALF is challenging by use of the established scores. In our case, improvement of enzymatic liver function measured by the LiMAx test was the first parameter predicting beneficial outcome in a patient with ALF complicated by sepsis.
Literature
1.
go back to reference Bower WA, Johns M, Margolis HS, Williams IT, Bell BP. Population-based surveillance for acute liver failure. Am J Gastroenterol. 2007;102:2459–63.CrossRefPubMed Bower WA, Johns M, Margolis HS, Williams IT, Bell BP. Population-based surveillance for acute liver failure. Am J Gastroenterol. 2007;102:2459–63.CrossRefPubMed
2.
go back to reference Khashab M, Tector AJ, Kwo PY. Epidemiology of acute liver failure. Curr Gastroenterol Rep. 2007;9:66–73.CrossRefPubMed Khashab M, Tector AJ, Kwo PY. Epidemiology of acute liver failure. Curr Gastroenterol Rep. 2007;9:66–73.CrossRefPubMed
4.
go back to reference Donnelly MC, Hayes PC, Simpson KJ. Role of inflammation and infection in the pathogenesis of human acute liver failure: clinical implications for monitoring and therapy. World J Gastroenterol. 2016;22:5958–70.CrossRefPubMedPubMedCentral Donnelly MC, Hayes PC, Simpson KJ. Role of inflammation and infection in the pathogenesis of human acute liver failure: clinical implications for monitoring and therapy. World J Gastroenterol. 2016;22:5958–70.CrossRefPubMedPubMedCentral
5.
go back to reference Polson J, Lee WM. American Association for the Study of liver disease. AASLD position paper: the management of acute liver failure Hepatol Baltim Md. 2005;41:1179–97. Polson J, Lee WM. American Association for the Study of liver disease. AASLD position paper: the management of acute liver failure Hepatol Baltim Md. 2005;41:1179–97.
6.
go back to reference Tandon BN, Bernauau J, O’Grady J, Gupta SD, Krisch RE, Liaw YF, et al. Recommendations of the International Association for the Study of the liver subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol. 1999;14:403–4.CrossRefPubMed Tandon BN, Bernauau J, O’Grady J, Gupta SD, Krisch RE, Liaw YF, et al. Recommendations of the International Association for the Study of the liver subcommittee on nomenclature of acute and subacute liver failure. J Gastroenterol Hepatol. 1999;14:403–4.CrossRefPubMed
7.
go back to reference Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet Lond Engl. 2010;376:190–201.CrossRef Bernal W, Auzinger G, Dhawan A, Wendon J. Acute liver failure. Lancet Lond Engl. 2010;376:190–201.CrossRef
8.
go back to reference Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2008;14(Suppl 2):S67–79. Ichai P, Samuel D. Etiology and prognosis of fulminant hepatitis in adults. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2008;14(Suppl 2):S67–79.
9.
go back to reference Acharya SK, Batra Y, Hazari S, Choudhury V, Panda SK, Dattagupta S. Etiopathogenesis of acute hepatic failure: eastern versus western countries. J Gastroenterol Hepatol. 2002;17(Suppl 3):S268–73.CrossRefPubMed Acharya SK, Batra Y, Hazari S, Choudhury V, Panda SK, Dattagupta S. Etiopathogenesis of acute hepatic failure: eastern versus western countries. J Gastroenterol Hepatol. 2002;17(Suppl 3):S268–73.CrossRefPubMed
10.
go back to reference Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SHB, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947–54.CrossRefPubMed Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SHB, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 2002;137:947–54.CrossRefPubMed
11.
go back to reference Bernal W, Cross TJS, Auzinger G, Sizer E, Heneghan MA, Bowles M, et al. Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single Centre experience. J Hepatol. 2009;50:306–13.CrossRefPubMed Bernal W, Cross TJS, Auzinger G, Sizer E, Heneghan MA, Bowles M, et al. Outcome after wait-listing for emergency liver transplantation in acute liver failure: a single Centre experience. J Hepatol. 2009;50:306–13.CrossRefPubMed
12.
go back to reference Liou IW, Larson AM. Role of liver transplantation in acute liver failure. Semin Liver Dis. 2008;28:201–9.CrossRefPubMed Liou IW, Larson AM. Role of liver transplantation in acute liver failure. Semin Liver Dis. 2008;28:201–9.CrossRefPubMed
13.
go back to reference Wigg AJ, Gunson BK, Mutimer DJ. Outcomes following liver transplantation for seronegative acute liver failure: experience during a 12-year period with more than 100 patients. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2005;11:27–34. Wigg AJ, Gunson BK, Mutimer DJ. Outcomes following liver transplantation for seronegative acute liver failure: experience during a 12-year period with more than 100 patients. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2005;11:27–34.
14.
go back to reference O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.CrossRefPubMed O’Grady JG, Alexander GJ, Hayllar KM, Williams R. Early indicators of prognosis in fulminant hepatic failure. Gastroenterology. 1989;97:439–45.CrossRefPubMed
15.
16.
go back to reference Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King’s criteria. J Hepatol. 1997;26:62–8.CrossRefPubMed Anand AC, Nightingale P, Neuberger JM. Early indicators of prognosis in fulminant hepatic failure: an assessment of the King’s criteria. J Hepatol. 1997;26:62–8.CrossRefPubMed
17.
go back to reference Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB. 2010;12:139–46.CrossRefPubMedPubMedCentral Stockmann M, Lock JF, Malinowski M, Niehues SM, Seehofer D, Neuhaus P. The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery. HPB. 2010;12:139–46.CrossRefPubMedPubMedCentral
18.
go back to reference Stockmann M, Lock JF, Malinowski M, Seehofer D, Puhl G, Pratschke J, et al. How to define initial poor graft function after liver transplantation? - a new functional definition by the LiMAx test. Transpl Int Off J Eur Soc Organ Transplant. 2010;23:1023–32.CrossRef Stockmann M, Lock JF, Malinowski M, Seehofer D, Puhl G, Pratschke J, et al. How to define initial poor graft function after liver transplantation? - a new functional definition by the LiMAx test. Transpl Int Off J Eur Soc Organ Transplant. 2010;23:1023–32.CrossRef
19.
go back to reference Malinowski M, Jara M, Lüttgert K, Orr J, Lock JF, Schott E, et al. Enzymatic liver function capacity correlates with disease severity of patients with liver cirrhosis: a study with the LiMAx test. Dig Dis Sci. 2014;59:2983–91.CrossRefPubMed Malinowski M, Jara M, Lüttgert K, Orr J, Lock JF, Schott E, et al. Enzymatic liver function capacity correlates with disease severity of patients with liver cirrhosis: a study with the LiMAx test. Dig Dis Sci. 2014;59:2983–91.CrossRefPubMed
20.
go back to reference Kaffarnik MF, Ahmadi N, Lock JF, Wuensch T, Pratschke J, Stockmann M, et al. Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study. PLoS One. 2017;12:e0178237.CrossRefPubMedPubMedCentral Kaffarnik MF, Ahmadi N, Lock JF, Wuensch T, Pratschke J, Stockmann M, et al. Correlation between plasma endothelin-1 levels and severity of septic liver failure quantified by maximal liver function capacity (LiMAx test). A prospective study. PLoS One. 2017;12:e0178237.CrossRefPubMedPubMedCentral
21.
go back to reference Jara M, Bednarsch J, Malinowski M, Pratschke J, Stockmann M. Effects of oxaliplatin-based chemotherapy on liver function--an analysis of impact and functional recovery using the LiMAx test. Langenbeck's Arch Surg. 2016;401:33–41.CrossRef Jara M, Bednarsch J, Malinowski M, Pratschke J, Stockmann M. Effects of oxaliplatin-based chemotherapy on liver function--an analysis of impact and functional recovery using the LiMAx test. Langenbeck's Arch Surg. 2016;401:33–41.CrossRef
22.
go back to reference Bernal W, Hyyrylainen A, Gera A, Audimoolam VK, McPhail MJW, Auzinger G, et al. Lessons from look-back in acute liver failure? A single Centre experience of 3300 patients. J Hepatol. 2013;59:74–80.CrossRefPubMed Bernal W, Hyyrylainen A, Gera A, Audimoolam VK, McPhail MJW, Auzinger G, et al. Lessons from look-back in acute liver failure? A single Centre experience of 3300 patients. J Hepatol. 2013;59:74–80.CrossRefPubMed
23.
go back to reference Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol. 2004;40:192–7.CrossRefPubMed Bernal W, Wendon J. Liver transplantation in adults with acute liver failure. J Hepatol. 2004;40:192–7.CrossRefPubMed
24.
go back to reference McPhail MJW, Wendon JA, Bernal W. Meta-analysis of performance of Kings’s college hospital criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol. 2010;53:492–9.CrossRefPubMed McPhail MJW, Wendon JA, Bernal W. Meta-analysis of performance of Kings’s college hospital criteria in prediction of outcome in non-paracetamol-induced acute liver failure. J Hepatol. 2010;53:492–9.CrossRefPubMed
25.
go back to reference Wlodzimirow KA, Eslami S, Chamuleau RAFM, Nieuwoudt M, Abu-Hanna A. Prediction of poor outcome in patients with acute liver failure-systematic review of prediction models. PLoS One. 2012;7:e50952.CrossRefPubMedPubMedCentral Wlodzimirow KA, Eslami S, Chamuleau RAFM, Nieuwoudt M, Abu-Hanna A. Prediction of poor outcome in patients with acute liver failure-systematic review of prediction models. PLoS One. 2012;7:e50952.CrossRefPubMedPubMedCentral
26.
go back to reference Kremers WK, van IJperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatol Baltim Md. 2004;39:764–9.CrossRef Kremers WK, van IJperen M, Kim WR, Freeman RB, Harper AM, Kamath PS, et al. MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatol Baltim Md. 2004;39:764–9.CrossRef
27.
go back to reference Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatol Baltim Md. 2001;33:464–70.CrossRef Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatol Baltim Md. 2001;33:464–70.CrossRef
28.
go back to reference Cholongitas E, Theocharidou E, Vasianopoulou P, Betrosian A, Shaw S, Patch D, et al. Comparison of the sequential organ failure assessment score with the King’s college hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2012;18:405–12. Cholongitas E, Theocharidou E, Vasianopoulou P, Betrosian A, Shaw S, Patch D, et al. Comparison of the sequential organ failure assessment score with the King’s college hospital criteria and the model for end-stage liver disease score for the prognosis of acetaminophen-induced acute liver failure. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2012;18:405–12.
29.
go back to reference Katoonizadeh A, Decaestecker J, Wilmer A, Aerts R, Verslype C, Vansteenbergen W, et al. MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int off J Int Assoc study. Liver. 2007;27:329–34.CrossRef Katoonizadeh A, Decaestecker J, Wilmer A, Aerts R, Verslype C, Vansteenbergen W, et al. MELD score to predict outcome in adult patients with non-acetaminophen-induced acute liver failure. Liver Int off J Int Assoc study. Liver. 2007;27:329–34.CrossRef
30.
go back to reference Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatol Baltim Md. 2007;45:789–96.CrossRef Schmidt LE, Larsen FS. MELD score as a predictor of liver failure and death in patients with acetaminophen-induced liver injury. Hepatol Baltim Md. 2007;45:789–96.CrossRef
31.
go back to reference Ichai P, Legeai C, Francoz C, Boudjema K, Boillot O, Ducerf C, et al. Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2015;21:512–23. Ichai P, Legeai C, Francoz C, Boudjema K, Boillot O, Ducerf C, et al. Patients with acute liver failure listed for superurgent liver transplantation in France: reevaluation of the Clichy-Villejuif criteria. Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc. 2015;21:512–23.
32.
go back to reference Karvellas CJ, Pink F, McPhail M, Cross T, Auzinger G, Bernal W, et al. Predictors of bacteraemia and mortality in patients with acute liver failure. Intensive Care Med. 2009;35:1390–6.CrossRefPubMed Karvellas CJ, Pink F, McPhail M, Cross T, Auzinger G, Bernal W, et al. Predictors of bacteraemia and mortality in patients with acute liver failure. Intensive Care Med. 2009;35:1390–6.CrossRefPubMed
33.
go back to reference Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003;125:755–64. Vaquero J, Polson J, Chung C, Helenowski I, Schiodt FV, Reisch J, et al. Infection and the progression of hepatic encephalopathy in acute liver failure. Gastroenterology. 2003;125:755–64.
34.
go back to reference Antoniades CG, Berry PA, Wendon JA, Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol. 2008;49:845–61.CrossRefPubMed Antoniades CG, Berry PA, Wendon JA, Vergani D. The importance of immune dysfunction in determining outcome in acute liver failure. J Hepatol. 2008;49:845–61.CrossRefPubMed
35.
go back to reference Krenkel O, Mossanen JC, Tacke F. Immune mechanisms in acetaminophen-induced acute liver failure. Hepatobiliary Surg Nutr. 2014;3:331–43.PubMedPubMedCentral Krenkel O, Mossanen JC, Tacke F. Immune mechanisms in acetaminophen-induced acute liver failure. Hepatobiliary Surg Nutr. 2014;3:331–43.PubMedPubMedCentral
36.
go back to reference Zider AD, Zopey R, Garg R, Wang X, Wang TS, Deng JC. Prognostic significance of infections in critically ill adult patients with acute liver injury: a retrospective cohort study. Liver Int off J Int Assoc study. Liver. 2016;36:1143–50.CrossRef Zider AD, Zopey R, Garg R, Wang X, Wang TS, Deng JC. Prognostic significance of infections in critically ill adult patients with acute liver injury: a retrospective cohort study. Liver Int off J Int Assoc study. Liver. 2016;36:1143–50.CrossRef
37.
go back to reference Kaffarnik MF, Lock JF, Vetter H, Ahmadi N, Lojewski C, Malinowski M, et al. Early diagnosis of sepsis-related hepatic dysfunction and its prognostic impact on survival: a prospective study with the LiMAx test. Crit Care Lond Engl. 2013;17:R259.CrossRef Kaffarnik MF, Lock JF, Vetter H, Ahmadi N, Lojewski C, Malinowski M, et al. Early diagnosis of sepsis-related hepatic dysfunction and its prognostic impact on survival: a prospective study with the LiMAx test. Crit Care Lond Engl. 2013;17:R259.CrossRef
38.
go back to reference Lock JF, Kotobi AN, Malinowski M, Schulz A, Jara M, Neuhaus P, et al. Predicting the prognosis in acute liver failure: results from a retrospective pilot study using the LiMAx test. Ann Hepatol. 2013;12:556–62.PubMed Lock JF, Kotobi AN, Malinowski M, Schulz A, Jara M, Neuhaus P, et al. Predicting the prognosis in acute liver failure: results from a retrospective pilot study using the LiMAx test. Ann Hepatol. 2013;12:556–62.PubMed
Metadata
Title
Liver maximum capacity (LiMAx) test as a helpful prognostic tool in acute liver failure with sepsis: a case report
Authors
Matthias Buechter
Guido Gerken
Dieter P. Hoyer
Stefanie Bertram
Jens M. Theysohn
Viktoria Thodou
Alisan Kahraman
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Anesthesiology / Issue 1/2018
Electronic ISSN: 1471-2253
DOI
https://doi.org/10.1186/s12871-018-0538-0

Other articles of this Issue 1/2018

BMC Anesthesiology 1/2018 Go to the issue